T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Analyst Price Targets - Benzinga

SPY770.32+0.09%QQQ724.33−0.63%BTC/USD82,020.65−0.13%DIA520.66+0.98%GLD381.10+1.36%TLT80.26+1.73%

T2 BIOSYSTEMS INC by T2 Biosystems, Inc.

TTOOOTCEM

Trade with Public

Trade with Public

$0.00070

-0.13-99.48%

Last update: Oct 15, 9:30 AM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for T2 BIOSYSTEMS INC by T2 Biosystems, Inc. (TTOO).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Hold

Consensus RatingHold# Analysts1Avg. Consensus PT$5Upside to Avg. PT+714185.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 30, 2024	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$3→$5
Apr 29, 2024	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$12→$3

Analyst Ratings News

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and raises the price target from $3 to $5.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and lowers the price target from $12 to $3.

Benzinga Newsdesk

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $0.07

Alliance Global Partners analyst Ben Haynor maintains T2 Biosystems (NASDAQ:TTOO) with a Neutral and lowers the price target from $0.12 to $0.07.

Benzinga Newsdesk

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Alliance Global Partners analyst Ben Haynor maintains T2 Biosystems (NASDAQ:TTOO) with a Neutral and lowers the price target from $2.2 to $1.5.

Benzinga Newsdesk

Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%

Wells Fargo cut the price target on Tesla, Inc. (NASDAQ: TSLA) from $280 to $230. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating on the stock. Tesla shares fell 0.4% to $220.85 in pre-market trading.

Lisa Levin

PRO
Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.

Benzinga Newsdesk